← Eichor
Condition: Cns Cancer Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Cns Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OPTIMIZATION of ADVANCED MR SEQUENCES
Phase N/A · 1 location(s) · Centre Hospitalier St Anne · NCT05618990Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
NA · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06282224Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06420076Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-
Phase 3 · 58 location(s) · NRG Oncology · NCT06500481Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric P
Phase 1 · 5 location(s) · ITM Solucin GmbH · NCT06441331Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
NA · 1 location(s) · Mayo Clinic · NCT04047264Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Phase N/A · 1 location(s) · Duke University · NCT05480644Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulm
Phase 1/Phase 2 · 31 location(s) · Novartis Pharmaceuticals · NCT07190300Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Phase N/A · 1 location(s) · Mayo Clinic · NCT06117930Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
Phase 1 · 1 location(s) · Mayo Clinic · NCT07456878MICRO-BRAIN 2024: Study on Pediatric Brain Tumors
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07417085Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Trea
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT07025226rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Phase 1 · 3 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT04943848A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Phase 1/Phase 2 · 10 location(s) · Eikon Therapeutics · NCT06907043Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06809517A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · 114 location(s) · Children's Oncology Group · NCT06368817Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Phase N/A · 1 location(s) · Stefan Lujinschi · NCT07575347Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
Phase 2 · 1 location(s) · Rongrong Zhou · NCT06702826Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · 231 location(s) · NRG Oncology · NCT04804644Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Phase 2 · 6 location(s) · Scott R. Plotkin, MD, PhD · NCT04374305Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
Phase 2 · 3 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT05215106Intraoperative Brain Shift Calculation Study
NA · 1 location(s) · Sklifosovsky Institute of Emergency Care · NCT05477680Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and
Phase 1 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT06914479Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Phase 1/Phase 2 · 1 location(s) · Stanford University · NCT03510208Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT06058988Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Phase 2 · 22 location(s) · Medical University of Vienna · NCT01356290A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
Phase 2 · 2 location(s) · University of Nebraska · NCT04222062A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Phase N/A · 2 location(s) · Chang Gung Memorial Hospital · NCT04805255NTS-WBRT in Brain Metastases
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05013892
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.